EMMBF - Emblem Corp.

Other OTC - Other OTC Delayed Price. Currency in USD
-0.08 (-8.62%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close0.96
Bid0.00 x 0
Ask0.00 x 0
Day's Range0.87 - 0.96
52 Week Range0.87 - 22.20
Avg. Volume178,142
Market Cap112.299M
PE Ratio (TTM)N/A
EPS (TTM)-0.10
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswire6 days ago

    Emblem inspires Canadians to Get Curious with the launch of new adult-use cannabis brand, Symbl

    Emblem Corp. (EMC.V) (EMC-WT.V) (“Emblem” or the "Company") today announced the launch of its first adult-use cannabis brand, Symbl. Leveraging Emblem’s existing brand strength in the medical market, Symbl was created to offer an equally thoughtful brand experience for those seeking cannabis for recreational use that fits within their productive lifestyle. Symbl was carefully crafted to be an approachable brand for Canadians as they navigate the new cannabis landscape come legalization on October 17, 2018.

  • GlobeNewswire11 days ago

    Emblem Completes Supply Agreement with Alberta Gaming, Liquor & Cannabis Commission (AGLC)

    Emblem Corp. (EMC.V) (EMC-WT.V) (“Emblem” or the "Company") is pleased to announce that its wholly owned subsidiary, Emblem Cannabis Corporation, one of Canada’s leading licensed producers, has completed an agreement with the Alberta Gaming, Liquor & Cannabis Commission (“AGLC”) to supply the province with high quality cannabis products. “Emblem is excited to have been selected to bring our adult-use products to Alberta’s recreational cannabis market upon legalization on October 17, 2018.

  • GlobeNewswire26 days ago

    Emblem to Launch Emblem Germany in Joint Venture with Acnos Pharma

    TORONTO, June 20, 2018-- Emblem Corp., is pleased to announce that its Board of Directors has approved the Company’ s formation of a joint venture under the name“ Emblem Germany” with German pharmaceutical ...

  • ACCESSWIRElast month

    Emblem Corp Making Smart Moves for Growth as Cannabis Legalization Moves Forward in Canada

    NEW YORK, NY / ACCESSWIRE / June 14, 2018 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive ...

  • GlobeNewswire2 months ago

    Emblem Corp. Reports 2018 First Quarter Results

    Strengthened team, new products, and key distribution partnerships driving demand. NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.. TORONTO, May 29, 2018-- ...

  • Benzinga2 months ago

    4 Potential Takeout Candidates In The Marijuana Sector

    A consolidation wave is sweeping across the marijuana industry, as companies aim to improve their competitive positioning and market share in an industry which offers a lot a promise. Aurora Cannabis Inc (OTC: ACBFF) recently announced a deal to buy MedReleaf Corp (OTC: MEDFF) in an all-cash transaction valued at C$3.2 billion. The proposed combination would mean a total funded capacity of over 570,000 kg per year of high-quality facilities in Canada and Denmark.

  • Analysts Are Slightly More Bullish on Supreme Cannabis in May
    Market Realist2 months ago

    Analysts Are Slightly More Bullish on Supreme Cannabis in May

    Supreme Cannabis (SPRWF) was in the news two days ago for its appointment of Colin Moore to its board of directors. Moore was previously the president of Starbucks Canada and has held positions with big brands such as PepsiCo and KFC. The mean ratings for the company changed from 1.8 in April, which is similar to Aurora Cannabis (ACB) and Canopy Growth (WEED), which have seen more bullish ratings month-over-month.

  • GlobeNewswire2 months ago

    Emblem and Canntab Therapeutics Announce Health Canada Approval for R&D of Cannabinoid-Based Oral Sustained Release Formulation

    Emblem Corp. (EMC.V) (EMC-WT.V) (“Emblem” or the "Company") and Canntab Therapeutics Limited (CSE:PILL) (“Canntab”) are pleased to announce the receipt of Health Canada approval for research and development activities on oral sustained release formulations of cannabinoids (the “Sustained Release Product” or the “Product”), which are the proprietary products conceived by Canntab representing significant progress in Emblem and Canntab’s partnership to develop long-acting cannabis formulations. “Product innovation, new formulations and dosage forms are critical pillars in Emblem’s competitive strength and growth strategy. Our licence agreement with Canntab is an important step in this direction. “We are thrilled that Health Canada has approved the research and development phase of our partnership with Canntab.

  • GlobeNewswire2 months ago

    Emblem Announces Settlement With Dissenting Shareholder

    Emblem Corp. (EMC.V) (EMC.WT) ("Emblem" or the "Corporation") announces that it has agreed to issue an aggregate of 482,758 common shares in the capital of Emblem (the “Common Shares”) to a former shareholder (the "Dissenting Shareholder") of Emblem’s predecessor KindCann Holdings Limited (“KindCann”). The Common Shares will be issued in settlement of statutory rights of dissent exercised by the Dissenting Shareholder in 2015 in respect of 2,000,000 Class A preferred shares of KindCann held by the Dissenting Shareholder. The Dissenting Shareholder exercised the statutory rights of dissent in connection with the amendment of KindCann’s articles to amend the share conditions attached to KindCann’s Class A preferred shares to provide KindCann’s board of directors with the discretion to pay the annual cash dividend afforded to the Class A preferred shares through the issuance of KindCann common shares.

  • GlobeNewswire2 months ago

    Emblem enters into Advisory Agreement with e.vestor Communications Inc.

    Emblem Corp. (EMC.V) (EMC-WT.V) ("Emblem" or the "Corporation") is pleased to announce the appointment of e.vestor Communications Inc. (“EVC”) as the Corporation’s capital markets and investor relations advisor through EVC’s principal, Cory Pala. EVC’s mandate will focus on providing capital markets guidance and support for Emblem through coordinated efforts to navigate the capital markets and support the Corporation’s continued listing on the Exchange. As consideration for the Services, the Corporation shall pay EVC a monthly fee of $10,000 to be paid out monthly.

  • ACCESSWIRE2 months ago

    Marijuana Stocks for Investors in the Free Cannabis Investor Magazine

    MIAMI, FL / ACCESSWIRE / May 7, 2018 / Cannabis Investor Magazine , the leading industry investment magazine for cannabis investors, analysts, executives, entrepreneurs, and financial media, announced ...

  • GlobeNewswire2 months ago

    Emblem Announces Appointment of Dan Milliard to its Board of Directors

    Emblem Corp. (EMC.V) (EMC-WT.V) ("Emblem" or the "Corporation") announces that the board of directors has appointed Dan Milliard to Emblem’s board of directors replacing Mr. Lorne Gertner who resigned in April 2018. “Dan has extensive board experience (as a Chartered Director), public markets experience, and business leadership experience. He will be invaluable to our Board, management team and shareholders as we enter the next phase of our growth strategy,” added Dean. In connection with the appointment, subject to receipt of the TSX Venture Exchange’s approval of Mr. Milliard’s appointment, the Corporation has approved the granting of 250,000 incentive stock options (the “Options”) to Mr. Milliard.

  • GlobeNewswire3 months ago

    Emblem Announces 2017 Financial Results

    NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.. TORONTO, April 27, 2018-- Emblem Corp., today reported its results for the fiscal year ended December ...

  • GlobeNewswire3 months ago

    Emblem Announces Investment in Fire & Flower

    NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.. TORONTO, April 23, 2018-- Emblem Corp., is pleased to announce that it has purchased C $2.5 million of ...